He is a clinical trialist and has more than 300 publications. He currently provides services to pharma and medical device companies in protocol development, data analyses, pharmacovigilance, data and safety monitoring, and regulatory submissions. He has served as CMO of a biotech company and has a special interest in new therapeutics for cardiovascular, ophthalmic, and orphan diseases.